Gaudium IVF and Women Health Ltd
Gaudium IVF and Women Health Ltd (GAUDIUMIVF) last reported results for the quarter ended Jun 2026, with sales of ₹19.38 crore and net profit of ₹1.78 crore. The stock last traded at ₹108, a market capitalisation of ₹788 crore, on a P/E of 34.0. Over the past 52 weeks the stock has ranged between ₹69.2 and ₹164. Figures are as of 6 Oct 2026 and are not real time.
Gaudium IVF and Women Health Ltd share price and key metrics
- Current price
- ₹108
- Market cap
- ₹788 cr
- Stock P/E
- 34.0
- Book value
- ₹20.9
- ROE
- 24.7%
- ROCE
- 29.3%
- Dividend yield
- 0.00%
- 52w high / low
- 164/69.2
Metrics as of 6 Oct 2026. Not real time.
Track Gaudium IVF and Women Health Ltd
Cruxal reads every Gaudium IVF and Women Health Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Gaudium IVF and Women Health Ltd growth and returns
- 10 Years
- %
- 5 Years
- %
- 3 Years
- 33%
- TTM
- 48%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- 22%
- TTM
- 28%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- 1 Year
- %
- 10 Years
- %
- 5 Years
- 41%
- 3 Years
- 34%
- Last Year
- 25%
Gaudium IVF and Women Health Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹19.38 cr, up 9.1% from ₹17.76 cr a year earlier. Net profit was ₹1.78 cr, down 42.0% year on year.
| ₹ crore | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|
| Sales | 14.42 | 26.92 | 17.76 | 31.73 | 24.51 | 30.35 | 19.38 |
| Expenses | 8.76 | 18.2 | 12.61 | 17.96 | 17.95 | 18.18 | 16.95 |
| Operating profit | 5.66 | 8.72 | 5.15 | 13.77 | 6.56 | 12.17 | 2.43 |
| OPM % | 39.25% | 32.39% | 29.00% | 43.40% | 26.76% | 40.10% | 12.54% |
| Other income | 0 | 0.23 | 0 | 0.15 | 0.1 | 0.18 | 1.12 |
| Interest | 0.39 | 0.43 | 0.5 | 0.51 | 1.2 | 1.29 | 0.38 |
| Depreciation | 0.58 | 0.36 | 0.61 | 0.61 | 0.49 | 0.64 | 0.72 |
| Profit before tax | 4.69 | 8.16 | 4.04 | 12.8 | 4.97 | 10.42 | 2.45 |
| Tax % | 27.72% | 20.96% | 24.01% | 26.64% | 26.96% | 19.77% | 27.76% |
| Net profit | 3.4 | 6.46 | 3.07 | 9.38 | 3.63 | 8.36 | 1.78 |
| EPS (₹) | 0.55 | 1.05 | 0.50 | 1.53 | 0.59 | 1.15 | 0.24 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Gaudium IVF and Women Health Ltd annual results
| ₹ crore | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|
| Sales | 37 | 44 | 48 | 71 | 104 | 106 |
| Operating profit | 14 | 20 | 19 | 29 | 38 | 35 |
| OPM % | 37% | 46% | 41% | 41% | 36% | 33% |
| Net profit | 9 | 14 | 10 | 19 | 24 | 23 |
| EPS (₹) | 89.17 | 136.54 | 104.22 | 3.12 | 3.36 | 3.51 |
TTM is the trailing twelve months to the most recent quarter.
Gaudium IVF and Women Health Ltd balance sheet
| ₹ crore | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Equity capital | 0.99 | 0.99 | 0.99 | 31 | 36 |
| Reserves | 8 | 22 | 26 | 16 | 116 |
| Borrowings | 6 | 12 | 17 | 21 | 25 |
| Other liabilities | 3 | 2 | 7 | 22 | 16 |
| Total liabilities | 18 | 37 | 51 | 89 | 193 |
| Fixed assets | 4 | 18 | 19 | 18 | 30 |
| CWIP | 0 | 0 | 0 | 7 | 0 |
| Investments | 0 | 0 | 0 | 5 | 5 |
| Other assets | 14 | 18 | 32 | 58 | 158 |
| Total assets | 18 | 37 | 51 | 89 | 193 |
As reported by the company. Total assets equal total liabilities by construction.
Gaudium IVF and Women Health Ltd cash flow
| ₹ crore | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Cash from operations | -1 | 24 | 3 | 9 | 7 |
| Cash from investing | -1 | -16 | -5 | -15 | -88 |
| Cash from financing | 3 | 5 | -1 | 2 | 82 |
| Net cash flow | 0 | 13 | -3 | -5 | 2 |
| Free cash flow | -2 | 9 | 1 | -0 | 5 |
| CFO / operating profit | 13% | 141% | 27% | 46% | 51% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Gaudium IVF and Women Health Ltd operating ratios
| Per year | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| ROCE % | — | 76% | 45% | 49% | 29% |
| Debtor days | 65 | 8 | 104 | 170 | 187 |
| Inventory days | 29 | 111 | 168 | 175 | 38 |
| Days payable | 114 | 77 | 62 | 338 | 133 |
| Cash conversion cycle | -20 | 41 | 210 | 7 | 92 |
| Working capital days | 61 | -52 | -15 | 44 | 91 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Gaudium IVF and Women Health Ltd shareholding pattern
Promoters held 71.29% at Jun 2026, broadly unchanged since Mar 2026. FIIs 3.01% and DIIs 2.22%.
| % held | Mar 2026 | Jun 2026 |
|---|---|---|
| Promoters | 71.29% | 71.29% |
| FIIs | 6.70% | 3.01% |
| DIIs | 2.63% | 2.22% |
| Public | 19.39% | 23.47% |
| No. of shareholders | 19,854 | 21,910 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Cruxal coverage of Gaudium IVF and Women Health Ltd
Gaudium IVF and Women Health Ltd corporate filings
- Corporate Scrutinizer Reports Confirm Approval of Key Resolutions in Gaudium IVF AGM 2026AGM/EGMhigh impact
Cruxal's analysis: Gaudium IVF's recent AGM saw all resolutions, including financial statements, director…
Read the full analysis - Gaudium IVF and Women Health Limited Concludes 11th Annual General Meeting; Focuses on Institutional Healthcare TransitionAGM/EGMlow impact
Cruxal's analysis: Gaudium IVF and Women Health Limited has successfully concluded its 11th Annual General…
Read the full analysis - Gaudium IVF and Women Health Limited has informed the Exchange regarding the closure of Trading Window pursuant to SEBI (Prohibition of Insider Trading) Regulation, 2015Insider Trading / SASTlow impact
- Gaudium IVF commences commercial operations at new Gurgaon centreCompany Updatemedium impact
Cruxal's analysis: Gaudium IVF and Women Health Ltd has officially commenced commercial operations at its…
Read the full analysis - Gaudium IVF and Women Health Ltd announces newspaper publication for 11th Annual General MeetingCompany Updatelow impact
Cruxal's analysis: Gaudium IVF and Women Health Ltd has published a newspaper advertisement regarding the…
Read the full analysis - Gaudium IVF and Women Health Ltd releases Annual Report for FY 2025-26Company Updatelow impact
Cruxal's analysis: Gaudium IVF and Women Health Ltd has provided the weblink and navigation path for…
Read the full analysis - Gaudium IVF and Women Health Ltd releases Annual Report for FY 2025-26Otherslow impact
Cruxal's analysis: Gaudium IVF and Women Health Ltd has filed its Annual Report for the financial year…
Read the full analysis - Gaudium IVF and Women Health Limited Announces 11th AGM and Proposes Significant Remuneration Revisions for PromotersAGM/EGMmedium impact
Cruxal's analysis: Gaudium IVF and Women Health Limited has issued a notice for its 11th Annual General…
Read the full analysis - Gaudium IVF and Women Health Limited schedules 11th Annual General Meeting for September 28, 2026Company Updatelow impact
Cruxal's analysis: Gaudium IVF and Women Health Limited has issued a formal notice for its 11th Annual…
Read the full analysis - Gaudium IVF Q1 FY27 Earnings: Revenue Grows 9.1% YoY Amidst Strategic Expansion and Margin CompressionCompany Updatemedium impact
Cruxal's analysis: Gaudium IVF and Women Health Limited reported Q1 FY27 revenue of 19.4 crore, a 9.1% YoY…
Read the full analysis - Gaudium IVF and Women Health Limited uploads audio recording of Q1 FY27 earnings callCompany Updatelow impact
Cruxal's analysis: Gaudium IVF and Women Health Limited has formally disclosed the availability of the audio…
Read the full analysis - Gaudium IVF and Women Health Limited Reports Unaudited Financial Results for Quarter Ended June 30, 2026Company Updatelow impact
Cruxal's analysis: Gaudium IVF and Women Health Limited has formally published its unaudited standalone and…
Read the full analysis - Gaudium IVF and Women Health Limited Issues Revised Q1 FY27 Investor Presentation with Adjusted EBITDA DisclosuresCompany Updatemedium impact
Cruxal's analysis: Gaudium IVF and Women Health Limited has released a revised investor presentation for the…
Read the full analysis - Gaudium IVF Q1 FY27 Results: Revenue Growth Offset by Strategic Expansion CostsCompany Updatehigh impact
Cruxal's analysis: Gaudium IVF and Women Health Limited reported Q1 FY27 consolidated revenue of 19.38…
Read the full analysis - Gaudium IVF and Women Health Ltd files Monitoring Agency Report for quarter ended June 30, 2026Company Updatelow impact
Cruxal's analysis: The company has submitted its Monitoring Agency Report for the quarter ended June 30…
Read the full analysis - Gaudium IVF Q1 FY27 Results: Revenue Grows 9.13% YoY Amidst Strategic Expansion-Led Margin CompressionCompany Updatemedium impact
Cruxal's analysis: Gaudium IVF and Women Health Limited reported Q1 FY27 revenue of 19.4 crore, a 9.13% YoY…
Read the full analysis - Gaudium IVF and Women Health Ltd files Statement of Deviation or Variation for quarter ended June 30, 2026Company Updatelow impact
Cruxal's analysis: The company has submitted its Statement of Deviation or Variation regarding the…
Read the full analysis - Gaudium IVF Reports Q1 FY27 Financials and Reallocates Unutilized IPO ProceedsBoard Meetingmedium impact
Cruxal's analysis: Gaudium IVF and Women Health Limited reported Q1 FY27 consolidated revenue of 19.38 crore…
Read the full analysis - Gaudium IVF and Women Health Ltd schedules Q1 FY2027 earnings conference call for August 14, 2026Company Updatelow impact
Cruxal's analysis: Gaudium IVF and Women Health Ltd has announced an earnings conference call to discuss its…
Read the full analysis - Gaudium IVF and Women Health Limited schedules Board Meeting for August 13, 2026, to approve Q1 FY27 financial resultsBoard Meetinglow impact
Cruxal's analysis: Gaudium IVF and Women Health Limited has issued a formal intimation regarding a Board of…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.